OCELLOS by TrakCel helps patients receive the right therapy at the right time
Cardiff, Wales (UK) and San Francisco, CA, February 17, 2021 – TrakCel today announces it has launched OCELLOS by TrakCel on Salesforce AppExchange, providing an end-to-end solution that connects Healthcare Providers, Supply Chain, Manufacturing, IT, Quality, Clinical Trial and Commercial teams all from one platform.
Leveraging a modular framework, OCELLOS by TrakCel can scale to support cellular therapies at each phase along the journey and seamlessly integrates with 3rd party systems via its Mulesoft™ powered Integration Hub. OCELLOS by TrakCel builds on the extensive experience the company has gained across their live, multi-lingual deployments for Autologous therapies (CAR-T, MIL, TIL, CRISPR), Matched Allogeneic therapies and Personalized Cancer Vaccines.
Built on the Salesforce Platform, OCELLOS by TrakCel is currently available on AppExchange here.
OCELLOS by TrakCel
TrakCel is one of the first orchestration platforms for the cell and gene therapy industry available on Salesforce AppExchange—the world’s leading enterprise cloud marketplace.
Comments on the News
- “The cell and gene therapy industry continues to develop more complex therapies for wider indications and larger patient volumes. As a result, this has required an evolution in TrakCel’s cellular orchestration product offering.” Fiona Withey, Chief Executive Officer, TrakCel.
About Salesforce AppExchange
Salesforce AppExchange, the world’s leading enterprise cloud marketplace, empowers companies to sell, service, market and engage in entirely new ways. With more than 6,000 listings, 8 million customer installs and 90,000 peer reviews, it is the most comprehensive source of cloud, mobile, social, IoT, analytics and artificial intelligence technologies for businesses.
- Like Salesforce on Facebook:http://www.facebook.com/salesforce
- Follow Salesforce on Twitter: https://twitter.com/salesforce
TrakCel is a market leading developer of integrated technologies specifically created in 2012 to manage the international cell, gene and immunotherapy supply chain. TrakCel’s software platform has been developed in collaboration with, and increasingly adopted by leading companies in the cell, gene and immunotherapy industries. TrakCel’s solutions deliver real-time control over the entire therapeutic supply chain, from sample collection through manufacturing to treatment delivery. The TrakCel platform accelerates global scale-up and scale-out of cell and gene therapy products, increasing efficiency and decreasing complexity, while maintaining treatment collection to administration compliance and traceability. TrakCel is headquartered in Cardiff, Wales, UK with US offices in California and New Jersey.
Article by TrakCel Marketing Team - 25 Feb 2021